Most models of tumorigenesis assume that the tumor grows by increased cell division. In these models, it is generally supposed that daughter cells behave as do their parents, and cell numbers have clear potential for exponential growth. We have constructed simple mathematical models of tumorigenesis through failure of programmed cell death (PCD) or differentiation. These models do not assume that descendant cells behave as their parents do. The models
growth. We have constructed simple mathematical models of tumorigenesis through failure of programmed cell death (PCD) or differentiation. These models do not assume that descendant cells behave as their parents do. The models predict that exponential growth in cell numbers does sometimes occur, usually when stem cells fail to die or differentiate. At other times, exponential growth does not occur: instead, the number of cells in the population reaches a new, higher equilibrium. This behavior is predicted when fully differentiated cells fail to undergo PCD. When cells of intermediate differentiation fail to die or to differentiate further, the values of growth parameters determine whether growth is exponential or leads to a new equilibrium. The predictions of the model are sensitive to small differences in growth parameters. Failure of PCD and differentiation, leading to a new equilibrium number of cells, may explain many aspects of tumor behavior-for example, early premalignant lesions such as cervical intraepithelial neoplasia, the fact that some tumors very rarely become malignant, the observation of plateaux in the growth of some solid tumors, and, finally, long lag phases of growth until mutations arise that eventually result in exponential growth.
The control of the cell cycle and cell death are frequently deranged in tumors (1) . The most frequently mutated locus in tumors, TP53 (2) , is centrally involved in pathways leading to programmed cell death (PCD) (3) (4) (5) . Failure of PCD may be important in causing the development of a tumor and in determining its response to antitumor therapy (6) . The precise role of PCD in tumorigenesis is, however, still unclear. There are several ways in which the failure of PCD might lead to or promote tumor growth. One such way may be to give cells the equivalent of a replicative advantage, whereby failure to die is effectively the same as more rapid cell division. Alternatively, the failure of PCD may lead to an increase in the intrinsic mutation rate by permitting cells to live on into senescence and be exposed to mutagens or acquire more spontaneous mutations. Failure of PCD can be regarded as a special case of failure of cell differentiation, which may be of general importance in tumorigenesis.
Basic models of tumorigenesis assume that the tumor grows by increased cell division (7) (8) (9) (10) 
At equilibrium,
There is, as expected, a unique point of equilibrium at which the population of stem cells exactly renews itself. If a3 rises above or falls below 0.5, No respectively increases or decreases exponentially.
For F1, N1(G + 1) = 2,f3N1(G)tO/tj + 2a2No(G), [3] and at equilibrium [5] and at equilibrium
As for Fl, there exist multiple equilibria depending on NI(G), 12 , y, t2, and t1. However, when N1 is at equilibrium, so is N2.
The simple results illustrate the increased complexity of behavior that accompanies models that consider cell differentiation and PCD. Parameters [7] At equilibrium
Therefore, a change in the proportion of differentiated cells undergoing apoptosis does not lead to exponential tumor growth but rather to a new equilibrium. When 8 < 0, N2(G) will be larger than before, and when 8 > 0, N2(G) will be smaller than before. Clearly, if -y + 8 0, N2 can be very large at equilibrium. N1 and No populations are always unchanged. Fig.   1 shows how N2(G) depends on 8 for representative values of 132, N1, t2, t1, and y. 13) ]Nl(G)to/t, + 2a2No(G), [9] and at equilibrium [11] If this condition is fulfilled, cell numbers in the F1 population undergo exponential growth, but they do not do so otherwise. In the model of normal cell differentiation, the condition 2933to/tl > 1 must hold for the population not to reach equilibrium. Therefore, the tendency to nonequilibrium is made more likely by the term 28613(tO/t1)/(P2 + 13) (when 8 is positive). Again, however, failure of PCD does not necessarily lead to exponential tumor growth. Thus, when 8 is less than the limit given in Eq. 11, N1(G) simply approaches a new, higher equilibrium. At each such stage, however, the probability that a decrease in 13i caused by a new mutation then leads to exponential growth of F1 cells (and hence of the tumor overall) must increase.
No is unchanged here. For F2 in this case, however, There is no equilibrium when these special conditions are not met (6 = [18] and at equilibrium 2a2NO(G)-
There is no equilibrium and there is exponential growth in cell = 2132(1 + w)N1(G)to/tj + (1 -Yto/t2)N2(G), [20] and at equilibrium 2132(1 + w)N1(G)t2
[ 21] Hence, this proliferative advantage does not overcome apoptosis to cause exponential tumor growth, although it does increase the number of cells at equilibrium by (1 + w), perhaps a small quantity. Similarly, if cells in Fo gained the proliferative advantage w' and differentiated into Fl cells, N1(G + 1) = 2P33N1(G)tO/tj + 2a2No(G)(1 + w'), [22] and at equilibrium N, (G) = 2a2NO(G)(1 + w') [3 1 -21A33t/tl [23] Hence, the conditions for equilibrium are unchanged from the normal population, although the number of cells at any time is increased by (1 + w'). Without PCD and differentiation, cell numbers in each generation would have been given by (1 + w')G. [24]
There is no equilibrium, and the situation is formally very similar to Eq. 16 and at equilibrium
and there is no equilibrium when 213(1 + W"')tO/tl > 1.
Hence, the effects on semidifferentiated cells are again to make equilibrium less likely but not necessarily to abolish it. The situation is formally almost identical to Eqs. 18 and 19 in Model 6 above.
The models in this section show that cell proliferation that might otherwise have been considered to lead to tumorigenesis may not do so under a situation where cells differentiate and undergo PCD. In some cases, however, proliferation may substitute for the failure of PCD or differentiation in leading to tumor growth.
Conclusions
The failure of PCD or differentiation is sometimes sufficient but is not necessary for tumorigenesis. When stem cells (Fo here) fail to undergo PCD or to differentiate in the models above, exponential growth in cell numbers occurs. This result is intuitive: extra stem cells produce both more differentiated cells and more stem cells, which in turn produce yet more stem cells and so on. This situation is formally very similar to that of tumorigenesis via stem cell proliferation, which also can result in an exponential growth in cell numbers. These are powerful mechanisms for causing tumors to develop.
If, however, a mutation causes semidifferentiated cells (Fl in the models) to fail to undergo PCD or to differentiate further, exponential tumor growth does not always result. Sometimes, the cell population reaches an equilibrium at higher numbers than normal; sometimes, exponential growth occurs. As long as the Fo is at equilibrium, whether the F1 population reaches equilibrium or shows exponential growth depends solely on whether a particular function of the parameters of cell replication exceeds some threshold value (see above).
Since the F1 population is potentially self-renewing like the stem cell Fo population, why does exponential growth not always occur in the former when PCD or differentiation fails? The answer is that the semidifferentiated F1 cell population is normally only partly self-renewing: many cells arise not just from the previous generation's F, but also from the Fo population. In (12) . Once equilibrium has been attained, there may be a delay until a new mutation occurs to cause further growth, whether exponential or to another equilibrium; but each such new state reached increases the chance that a further mutation, advantageous to tumorigenesis, will lead to exponential growth and to malignancy.
The interaction between failure of PCD and tumor growth via cell proliferation has been commented on by many workers (13) (14) (15) This is, however, an extreme case and unlikely to apply in reality, since apoptosis probably includes some stochastic element and is unlikely to apply uniformly to a population of differentiated cells.
The models have been deliberately imprecise as to the type of mutation that might lead to the differences proposed in the proportion of cells undergoing PCD or differentiation. While the roles of genes such as TP53, MYC, and BCL2 in PCD are being discovered (5, (16) (17) (18) (19) (20) (21) , the pathways that lead to apoptosis are likely to be complex and varied. There is little virtue in incorporating such complexity into models of tumorigenesis. It is sufficient to ensure that the assumptions made in the models are not known to be unrealistic in any important feature. Further developments of the model will include simulations of stochastic effects and incorporation of successive mutational steps, with mutation rates and selective parameters chosen from appropriate distributions.
In summary, the models presented illustrate the possible roles played in tumorigenesis by the failure of PCD in particular and of differentiation in general. Perhaps most importantly, they show that the incorporation of differentiation and PCD into genetic models of tumor growth can have profound effects. Tumors may, for example, grow to some equilibrium rather than the continuing exponential growth that might have been expected. Which path the tumor follows depends on functions of growth parameters, on the values of those parameters and on the stage of differentiation of the cell that fails to apoptose or differentiate. Small changes in these parameters, causing them to exceed or fall below threshold values, can profoundly alter tumor behavior. We believe, therefore, that these models provide effective explanations for the development of benign tumors and premalignant growths as well as the stepwise, gradual growth of many tumors, with sometimes very long apparent lag phases.
